- Home
- Clinical Trials
Bambusa COPD Study LP
Bambusa COPD Study
Do you have COPD? Are current treatments not giving you the relief you need?
You may be eligible for a clinical research study investigating the safety of a potential new medication designed to target and reduce inflammation in the airways, with the aim to improve breathing, reduce flare-ups and ease daily symptoms.
By joining, you may receive early access to a potential new medication, receive regular health checks, and contribute to research that may benefit others living with COPD.
Study details
Ages
35-80
Duration
The study has a duration of approximately 28 weeks and involves 14 clinic visits
Compensation
Participants will be reimbursed for time and study-related costs.
Eligibility Criteria
You may qualify for this study if you:
- Are 35 to 80 years old
- Have been clinically diagnosed with COPD for at least 6 months
- Have been using an inhaler to treat your COPD for at least 3 months
- Are a current or former cigarette smoker
- Have a body mass index (BMI) of at least 16 kg/m2 and weigh less than 125kg
Other criteria will apply. Register your interest for the study at your preferred clinic location to find out more.
Find A Study Near You
Find A Study Near You
Register your interest in this study at your preferred clinic location and our study team will be in touch.
Find A Study Near You
Find A Study Near You
Register your interest in this study at your preferred clinic location and our study team will be in touch.